Possible role of vitamin D supplementation in coronavirus disease 2019

Authors

  • Devi Dayal Endocrinology and Diabetes Unit, Department of Pediatrics, 3108, Level III, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh http://orcid.org/0000-0002-3279-6002

DOI:

https://doi.org/10.18203/issn.2454-2156.IntJSciRep20203554

Keywords:

Coronavirus disease 2019, COVID-19, Vitamin D deficiency, Treatment, Vitamin D supplementation, Children

Abstract

Vitamin D deficiency (VDD) is presumed to play a role in several infective and non-infective conditions such as acute respiratory infections, tuberculosis, diabetes, hypertension, stroke etc. Most of the respiratory viral infections occur during winter season when the vitamin D levels in most individuals are generally low. The current pandemic of coronavirus disease 2019 (COVID-19) which began during winter season similar to the previous epidemics due to coronaviruses, has again stirred a debate on the role of VDD in the initiation and spread of the pandemic. The data on vitamin D status in patients with COVID-19 is however lacking. Different vitamin D supplementation strategies have recently been suggested as part of several countermeasures aimed at reducing the impact of COVID-19 pandemic. This brief narrative review discusses the evidence for the link between VDD and COVID-19 and the approaches suggested for vitamin D supplementation.

Metrics

Metrics Loading ...

Author Biography

Devi Dayal, Endocrinology and Diabetes Unit, Department of Pediatrics, 3108, Level III, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh

Professor

References

Solnika A, Barski L, Jotkowitz A. Allocation of scarce resources during the COVID-19 pandemic: A Jewish ethical perspective. J Med Ethics. 2020;46(7):444-6.

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A review. JAMA. 2020;323(18):1824-36.

World Health Organization. Monitored emergency use of unregistered and experimental interventions (MEURI). Available at: https://www.who.int/ethics/publications/infectious-disease-outbreaks/en/. Accessed on: 31 April 2020.

Caccialanza R, Laviano A, Lobascio F, Montagna E, Bruno R, Ludovisi S, Corsico AG et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition. 2020;74:110835.

McCartney DM, Byrne DG. Optimisation of vitamin D status for enhanced immuno-protection against covid-19. Ir Med J. 2020;113(4):58.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.

Dayal D. We urgently need guidelines for managing COVID-19 in children with comorbidities. Acta Paediatr. 2020;109(7):1497-8.

Dayal D, Yadav A. COVID-19: Considerations for Children and Adolescents with Diabetes. J Diabetol. 2020;11(3):doi: 10.4103/jod.jod_40_20 (in press).

Molloy EJ, Murphy N. Vitamin D, Covid-19 and Children. Ir Med J. 2020;113(4):64.

Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Asses. 2019;23(2):1-44.

Borkar VV, Devidayal, Verma S, Bhalla AK. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2010;11(5):345-50.

Dayal D, Sachdeva N. Preservation of residual beta cell functions with vitamin D supplementation in type 1 diabetes. Immunoendocrinology. 2015;2:1093.

De Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol. 2018;419:1-42.

Yousefzadegan S, Rezaei N. Case Report: Death due to novel coronavirus disease (COVID-19) in three brothers. Am J Trop Med Hyg. 2020;102(6):1203-4.

VitaminD in COVID-19. Available at: https://clinicaltrials.gov/ct2/results?cond=COVID-19+vitamin D. Accessed on April 14, 2020.

Dayal D, Jayaraman D. Vitamin D deficiency: Dealing with the current epidemic. In: Current Pediatrics Practice. New Delhi: Peepee Publishers. 2015;69-75.

Lee YM, Kim SA, Lee DH. Can current recommendations on sun exposure sufficiently increase serum vitamin D Level?: One-Month Randomized Clinical Trial. J Korean Med Sci. 2020;35(8):50.

Dayal D, Kumar S, Sachdeva N, Kumar R, Singh M, Singhi S. Fall in vitamin D levels during hospitalization in children. Int J Pediatr. 2014;2014:291856.

Patseadou M, Haller DM. Vitamin D in adolescents: A systematic review and narrative synthesis of of available recommendations. J Adolesc Health. 2020;66(4):388-407.

Schall JI, Hediger ML, Zemel BS, Rutstein RM, Stallings VA. Comprehensive safety monitoring of 12-Month Daily 7000- IU vitamin D3 supplementation in human immunodeficiency virus-infected children and young adults. JPEN J Parenter Enteral Nutr. 2016;40(7):1057-63.

Panjiyar RP, Dayal D, Attri SV, Sachdeva N, Sharma R, Bhalla AK. Sustained serum 25-hydroxyvitamin D concentrations for one year with cholecalciferol supplementation improves glycaemic control and slows the decline of residual β cell function in children with type 1 diabetes. Pediatr Endocrinol Diabetes Metab. 2018;24(3):111-7.

Dayal D, Jain N. Indian children need higher vitamin D supplementation. Indian Pediatr. 2018;55(1):78.

Dayal D, Kumar L, Singh M. Non-bullous ichthyosiform erythroderma with rickets. Indian Pediatr. 2002;39(2):207-8.

Jain N, Dayal D, Muthuvel B. Vitamin D deficiency rickets in a child with xeroderma pigmentosum. Indian J Child Health. 2018;5(1):66-7.

Downloads

Published

2020-08-20

Issue

Section

Review Articles